The road to accessible CAR-T therapies: Inside a world-first innovation for decentralised leukapheresis
As the CAR-T field advances, so must today’s hospital-centric delivery models, which limit patient access to autologous therapies. We caught up with the team behind the first ever mobile leukapheresis center to see what community-based care could look like in the world of cell therapies.
